ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Angiogenesis"

  • Abstract Number: 1602 • 2012 ACR/ARHP Annual Meeting

    Tie2 Signalling Induces a Pro-Inflammatory and Pro-Angiogenic Phenotype in Differentiated Macrophages, Independently of Macrophage Polarization Conditions, and Contributes to Production of Cytokines Elevated in Early Rheumatoid Arthritis

    Samuel Garcia1, Sarah Krausz2, Carmen A. Ambarus3, Bea Malvar Fernandez2, Dominique L. Baeten4, Paul P. Tak5 and Kris A. Reedquist2, 1Department of Experimental Immunology, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 2Department of Experimental Immunology, Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 3Department Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 4Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 5Department of Experimental Immunology, Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and GlaxoSmithKline, Amsterdam, Netherlands

    Background/Purpose: Angiopoietin (Ang) -1 and -2 signalling to the Tie2 tyrosine kinase receptor has an essential role in blood vessel remodeling and angiogenesis.  Ang-1, Ang-2…
  • Abstract Number: 1603 • 2012 ACR/ARHP Annual Meeting

    Inhibitor of DNA Binding 1 As a Secreted Angiogenic Transcription Factor in Rheumatoid Arthritis

    Takeo Isozaki1, M. Asif Amin2, Alisa E. Koch3, Ali Arbab4, Stephanie A. Shuman1, Christine M. Ha1, G. Kenneth Haines III5 and Jeffrey H. Ruth6, 1Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 2Department of Medicine, University of Michigan, Ann Arbor, MI, 3Internal Medicine - Rheumatology, University of Michigan Medical School, Ann Arbor, MI, 4Diagnostic Radiology, Henry Ford Hospital and Medical Centers, Detroit, MI, 5Department of Pathology, Yale University, New Haven, CT, 6Internal Medicine, Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI

    Background/Purpose: Rheumatoid arthritis (RA) is characterized by enhanced blood vessel development in joint synovium. This involves the recruitment of endothelial progenitor cells (EPCs), allowing for…
  • Abstract Number: 1506 • 2012 ACR/ARHP Annual Meeting

    Primary Human Scleroderma Dermal Endothelial Cells Exhibit Defective Angiogenesis

    Pei-Suen Tsou1, Bradley J. Rabquer2, Beatrix Balogh2, Ann Kendzicky2, Bashar Kahaleh3, Elena Schiopu4, Dinesh Khanna5 and Alisa E. Koch6, 1Internal Medicine, Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI, 2University of Michigan Medical School, Ann Arbor, MI, 3Medicine/Rheumatology, University of Toledo, Toledo, OH, 4Rheumatology/Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, 5Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI, 6Internal Medicine - Rheumatology, University of Michigan Medical School, Ann Arbor, MI

    Background/Purpose: Angiogenesis, the formation of new blood vessels, plays a critical role in a number of pathological processes including systemic sclerosis (scleroderma, SSc). SSc is…
  • Abstract Number: 1511 • 2012 ACR/ARHP Annual Meeting

    Low Circulating Endothelial Progenitor Cell Levels and High VEGF Serum Levels Are Associated with the Late Nailfold Capillaroscopic Pattern in Systemic Sclerosis

    Jerome Avouac1, Maeva Vallucci2, Vanessa Smith3, Barbara Ruiz2, Alberto Sulli4, Carmen Pizzorni5, Gilles Chiocchia6, Maurizio Cutolo7 and Yannick Allanore8, 1Paris Descartes University, Rheumatology A department, Cochin Hospital, Paris, France, 2Paris Descartes University, INSERM U1016, Institut Cochin, Sorbonne Paris Cité, Paris, France, 3Department of Rheumatology, Ghent University Hospital, Ghent, Belgium, 4Research Laboratory and Academic Unit of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy, 5Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy, 6Immunology and Hematology Department, Institut Cochin - INSERM U1016 - CNRS (UMR 8104), Paris, France, 7Research Laboratory and Academic Unit of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genova, Italy, 8Rheumatology, Paris Descartes University, Rheumatology A department, Cochin Hospital, Paris, France

    Background/Purpose: To assess whether nailfold videocapillaroscopy (NVC) changes are associated with peripheral blood or serum levels of angiogenic biomarkers in systemic sclerosis (SSc). Methods: Endothelial…
  • Abstract Number: 1291 • 2012 ACR/ARHP Annual Meeting

    A Phase Ib Clinical Trial with F8-IL10, an Anti-Inflammatory Immunocytokine for the Treatment of Rheumatoid Arthritis (RA), Used in Combination with Methotrexate (MTX)

    Mauro Galeazzi1, Caterina Baldi1, Elena Prisco2, Marco Bardelli1, Dario Neri3, Leonardo Giovannoni4, Enrico Selvi1 and Roberto Caporali2, 1Rheumatology, University of Siena, Siena, Italy, 2Rheumatology, University of Pavia, IRCCS Policlinico San Matteo Foundation, Pavia, Italy, 3Chemistry and Applied Biosciences, Swiss Federal Institute of Technology Zurich, Zurich, Switzerland, 4Philogen S.p.A., Siena, Italy

    Background/Purpose: Interleukin 10 (IL10) is an anti-inflammatory cytokine potentially efficacious for RA. F8-IL10 is a fusion protein in which the cytokine is fused with the…
  • Abstract Number: 1191 • 2012 ACR/ARHP Annual Meeting

    Nicotinamide Adenine Dinucleotide Phosphate Oxidase Mediated Angiogenesis and Inflammation in the Arthritic Joint

    Monika Biniecka1, Wei Gao2, Chin Teck Ng1, Emese Balogh2, Douglas J. Veale2 and Ursula Fearon2, 1Rheumatology, Translation Research Group, Dublin Academic Medical Centre, St. Vincent's University Hospital, Dublin, Ireland, 2Dublin Academic Medical Centre, St. Vincent's University Hospital, Translation Rheumatology Research Group, Dublin, Ireland

    Background/Purpose: To examine the role of Nicotinamide Adenine Dinucleotide Phosphate Oxidase (NADPH oxidase)-derived Reactive Oxygen Species (ROS) and NADPH oxidase-dependent redox signaling events in regulating…
  • Abstract Number: 879 • 2012 ACR/ARHP Annual Meeting

    Fucosyltransferase 1 (fut1) Is Overexpressed in Rheumatoid Arthritis Synovial Tissue and Modifies Cytokine Production

    Takeo Isozaki1, Jeffrey H. Ruth2, M. Asif Amin1, Phillip L. Campbell1, Steven E. Domino3, G. Kenneth Haines III4 and Alisa E. Koch5, 1Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, 2Internal Medicine, Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI, 3Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, 4Department of Pathology, Yale University, New Haven, CT, 5Internal Medicine - Rheumatology, University of Michigan Medical School, Ann Arbor, MI

    Background/Purpose: Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by inflammation and joint destruction. Angiogenesis and cytokine production are involved in the pathogenesis of…
  • Abstract Number: 667 • 2012 ACR/ARHP Annual Meeting

    Interferon-Alpha Impairs the Survival and Function of Circulating Angiogenic Cells in Vitro: A Model of Failed Endothelial Repair in SLE

    John A. Reynolds1, David W. Ray2, Terence O'Neill3, M. Yvonne Alexander4 and Ian N. Bruce5, 1Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute of Inflammation and repair, Manchester Academic Health Science Centre, The University of Manchester, United Kingdom, Manchester, United Kingdom, 2Institute of Human Development, Institute of Human Development, The University of Manchester, Manchester, United Kingdom, 3Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester, United Kingdom, 4Healthcare Science Research Institute, Faculty of Science and Engineering, Healthcare Science Research Institute, Manchester Metropolitan University, Manchester, United Kingdom, 5Manchester Academic Health Science Centre, Arthritis Research UK Epidemiology Unit and NIHR Manchester Musculoskeletal Biomedical Research Unit, The University of Manchester, Manchester, United Kingdom

    Background/Purpose: Patients with Systemic Lupus Erythematosus have an increased risk of cardiovascular disease (CVD).  No specific targeted therapies for CVD in lupus exist and there…
  • Abstract Number: 589 • 2012 ACR/ARHP Annual Meeting

    NGF and Trka: A Novel Therapeutic Target in Chronic Inflammation

    Siba P. Raychaudhuri1, Ananya Datta Mitra2 and Smriti K. Raychaudhuri2, 1Rheumatology, VA Sacramento Medical Center/UC Davis School of Medicine, Mather, CA, 2Rheumatology, VA Sacramento Medical Center, Mather, CA

    Background/Purpose: Outside the nervous system, several studies have established the regulatory role of nerve growth factor (NGF) and its high affinity receptor, TrkA. A clinical…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology